At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the lives of patients following myocardial infarction by enabling faster recovery time and improved heart function.
Location: Switzerland, Wallis, Monthey
Employees: 1-10
Total raised: $11.3K
Founded date: 2023
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.08.2023 | Grant | $11.3K | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 15.04.2024 | CHF 500’000 pre-seed funding for Orio Therapeutics | Most protein-based therapeutics in regenerative medicine have limited success due to uncontrolled d... | startuptic... |
| 05.06.2023 | A significant number of Swiss biotechs exhibit in Boston | startuptic... | |
| - | Orio Therapeutics | “At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream access... | fastfounde... |